GOOD CLINICAL PRACTICE PREMIUM REVIEW
SET 2026 PRACTICE SOLUTION GUARANTEED
PASS
◉ What does Good Clinical Practice assure? Answer: Assurance that
the rights, safety, and well-being of trial subjects are protected,
consistent with the principles that have their origin in the
Declaration of Helsinki, and that the clinical trial data are credible.
◉ What is the objective Good Clinical Practice Guideline? Answer: To
provide a unified standard for the European Union
(EU), Japan, and the United States to facilitate the mutual acceptance
of clinical data by the regulatory authorities in these jurisdictions.
◉ Good Clinical Practice Guideline was developed by? Answer:
European Union, Japan, and the United States, as well as those of
Australia, Canada, the Nordic countries, and the World Health
Organization (WHO).
◉ When should Good Clinical Practice Guideline be followed?
Answer: When generating clinical trial data that are intended to be
submitted to regulatory authorities.
May also be applied to other clinical investigations that
may have an impact on the safety and well-being of human subjects.
,◉ What is Adverse drug reaction (ADR)? Answer: All noxious and
unintended responses to a medicinal product related to any dose.
A causal relationship between a medicinal product and an adverse
event.
◉ Adverse drug reaction (ADR) of marketed medicinal products:
Answer: A response to a drug that is noxious and unintended and
that occurs at doses normally used in man for prophylaxis,
diagnosis, or therapy of diseases or for modification of physiological
function
◉ Applicable regulatory requirement(s): Answer: Any law(s) and
regulation(s) addressing the conduct of clinical trials of
investigational products.
◉ Approval (in relation to Institutional Review Boards) Answer: The
affirmative decision of the IRB that the clinical trial has been
reviewed and may be conducted at the institution sit
◉ Audit Answer: A systematic and independent examination of trial
related activities and documents
◉ Audit Certificate Answer: A declaration of confirmation by the
auditor that an audit has taken place.
, ◉ Audit Report Answer: A written evaluation by the sponsor's
auditor of the results of the audit.
◉ Blinding/Masking Answer: One or more parties to the trial are
kept unaware of the treatment assignment(s).
◉ Single-blinding Answer: Usually refers to the subject(s) being
unaware
◉ Doubleblinding Answer: Usually refers to the subject(s),
investigator(s), monitor, and, in some cases, data analyst(s) being
unaware of the treatment assignment(s).
◉ Case Report Form (CRF) Answer: A printed, optical, or electronic
document designed to record all of the protocol required
information to be reported to the sponsor on each trial subject.
◉ Clinical Trial/Study Answer: Any investigation in human subjects
intended to discover or verify the clinical, pharmacological and
pharmacodynamic effects, record adverse reactions, safety or
efficacy of an investigational product(s).....
◉ Clinical Trial/Study Report Answer: A written description of a
trial/study of any therapeutic, prophylactic, or diagnostic agent
SET 2026 PRACTICE SOLUTION GUARANTEED
PASS
◉ What does Good Clinical Practice assure? Answer: Assurance that
the rights, safety, and well-being of trial subjects are protected,
consistent with the principles that have their origin in the
Declaration of Helsinki, and that the clinical trial data are credible.
◉ What is the objective Good Clinical Practice Guideline? Answer: To
provide a unified standard for the European Union
(EU), Japan, and the United States to facilitate the mutual acceptance
of clinical data by the regulatory authorities in these jurisdictions.
◉ Good Clinical Practice Guideline was developed by? Answer:
European Union, Japan, and the United States, as well as those of
Australia, Canada, the Nordic countries, and the World Health
Organization (WHO).
◉ When should Good Clinical Practice Guideline be followed?
Answer: When generating clinical trial data that are intended to be
submitted to regulatory authorities.
May also be applied to other clinical investigations that
may have an impact on the safety and well-being of human subjects.
,◉ What is Adverse drug reaction (ADR)? Answer: All noxious and
unintended responses to a medicinal product related to any dose.
A causal relationship between a medicinal product and an adverse
event.
◉ Adverse drug reaction (ADR) of marketed medicinal products:
Answer: A response to a drug that is noxious and unintended and
that occurs at doses normally used in man for prophylaxis,
diagnosis, or therapy of diseases or for modification of physiological
function
◉ Applicable regulatory requirement(s): Answer: Any law(s) and
regulation(s) addressing the conduct of clinical trials of
investigational products.
◉ Approval (in relation to Institutional Review Boards) Answer: The
affirmative decision of the IRB that the clinical trial has been
reviewed and may be conducted at the institution sit
◉ Audit Answer: A systematic and independent examination of trial
related activities and documents
◉ Audit Certificate Answer: A declaration of confirmation by the
auditor that an audit has taken place.
, ◉ Audit Report Answer: A written evaluation by the sponsor's
auditor of the results of the audit.
◉ Blinding/Masking Answer: One or more parties to the trial are
kept unaware of the treatment assignment(s).
◉ Single-blinding Answer: Usually refers to the subject(s) being
unaware
◉ Doubleblinding Answer: Usually refers to the subject(s),
investigator(s), monitor, and, in some cases, data analyst(s) being
unaware of the treatment assignment(s).
◉ Case Report Form (CRF) Answer: A printed, optical, or electronic
document designed to record all of the protocol required
information to be reported to the sponsor on each trial subject.
◉ Clinical Trial/Study Answer: Any investigation in human subjects
intended to discover or verify the clinical, pharmacological and
pharmacodynamic effects, record adverse reactions, safety or
efficacy of an investigational product(s).....
◉ Clinical Trial/Study Report Answer: A written description of a
trial/study of any therapeutic, prophylactic, or diagnostic agent
